DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4. (Q42237739)
Jump to navigation
Jump to search
scientific article published on 12 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4. |
scientific article published on 12 February 2014 |
Statements
1 reference
DAUPHINE: a randomized phase II study of danoprevir/ritonavir plus peginterferon alpha-2a/ribavirin in HCV genotypes 1 or 4. (English)
1 reference
Stefan Zeuzem
1 reference
Gregory Everson
1 reference
Curtis Cooper
1 reference
Christophe Hézode
1 reference
Mitchell L Shiffman
1 reference
Eric Yoshida
1 reference
Teresita Beltran-Jaramillo
1 reference
Pietro Andreone
1 reference
Savino Bruno
1 reference
Peter Ferenci
1 reference
Michael Brunda
1 reference
Sophie Le Pogam
1 reference
Isabel Nájera
1 reference
Julian Zhou
1 reference
Mercidita T Navarro
1 reference
Athina Voulgari
1 reference
Nancy S Shulman
1 reference
Ellen S Yetzer
1 reference
12 February 2014
1 reference
1 reference
35
1 reference
1
1 reference
108-119
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference